Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2022 0 · FY2023 0 · FY2024 889 — 3-yr total 889
Operates in Medical Devices — Distribution. Per the activity note to the FY2024 annual report, the company trades in medical equipment and medical supplies through re-export. Parent company is Estonian private company MN Medical.
Subsidiary of Shezghuduli Pasukhismgeblobis Kerdzo Company MN MEDICAL (100.0%)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | CAGR |
|---|---|---|---|---|---|---|---|---|
| 4,277 | 1,384 | 1,719 | 1,417 | 1,585 | 1,118 | 1,148 | -19.7% | |
| 59 | 369 | 10 | 6 | 2 | 1 | 1 | -48.0% | |
| TOTAL ASSETS | 4,336 | 1,016 | 1,728 | 1,423 | 1,586 | 1,119 | 1,149 | -19.9% |
| 3,491 | 1 | 635 | 3 | 4 | 10 | 3 | nmf | |
| Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| TOTAL LIABILITIES | 3,491 | 1 | 635 | 3 | 4 | 10 | 3 | nmf |
| 846 | 1,015 | 1,093 | 1,420 | 1,583 | 1,109 | 1,146 | +5.2% | |
| Balance Check (Assets - L&E) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Debt analysis | ||||||||
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Cash & Equivalents | 124 | 169 | 957 | 1,046 | 870 | 950 | 1,141 | +44.7% |
| Net Debt | 124 | 169 | 957 | 1,046 | 870 | 950 | 1,141 | +44.7% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set.